237 related articles for article (PubMed ID: 30654065)
1. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome.
Van Wettere M; Purcell Y; Bruno O; Payancé A; Plessier A; Rautou PE; Cazals-Hatem D; Valla D; Vilgrain V; Ronot M
J Hepatol; 2019 Jun; 70(6):1123-1132. PubMed ID: 30654065
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.
Van Wettere M; Paulatto L; Raynaud L; Bruno O; Payancé A; Plessier A; Rautou PE; Paradis V; Cazals-Hatem D; Valla D; Vilgrain V; Ronot M
JHEP Rep; 2020 Jun; 2(3):100097. PubMed ID: 32435753
[TBL] [Abstract][Full Text] [Related]
3. MR imaging features and long-term evolution of benign focal liver lesions in Budd-Chiari syndrome and Fontan-associated liver disease.
Panvini N; Dioguardi Burgio M; Sartoris R; Maino C; Van Wettere M; Plessier A; Payancé A; Rautou PE; Ladouceur M; Vilgrain V; Ronot M
Diagn Interv Imaging; 2022 Feb; 103(2):111-120. PubMed ID: 34654671
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome.
Sakr M; Abdelhakam SM; Dabbous H; Hamed A; Hefny Z; Abdelmoaty W; Shaker M; El-Gharib M; Eldorry A
Liver Int; 2017 Mar; 37(3):415-422. PubMed ID: 27507647
[TBL] [Abstract][Full Text] [Related]
5. Budd-Chiari Syndrome and hepatic regenerative nodules: Magnetic resonance findings with emphasis of hepatobiliary phase.
Mamone G; Carollo V; Di Piazza A; Cortis K; Degiorgio S; Miraglia R
Eur J Radiol; 2019 Aug; 117():15-25. PubMed ID: 31307641
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.
Moucari R; Rautou PE; Cazals-Hatem D; Geara A; Bureau C; Consigny Y; Francoz C; Denninger MH; Vilgrain V; Belghiti J; Durand F; Valla D; Plessier A
Gut; 2008 Jun; 57(6):828-35. PubMed ID: 18218675
[TBL] [Abstract][Full Text] [Related]
7. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar.
Maetani Y; Itoh K; Egawa H; Haga H; Sakurai T; Nishida N; Ametani F; Shibata T; Kubo T; Tanaka K; Konishi J
AJR Am J Roentgenol; 2002 Apr; 178(4):869-75. PubMed ID: 11906865
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
Liu FY; Wang MQ; Duan F; Fan QS; Song P; Wang Y
BMC Gastroenterol; 2013 Jun; 13():105. PubMed ID: 23800233
[TBL] [Abstract][Full Text] [Related]
9. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
10. Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma.
Shin SH; Chung YH; Suh DD; Shin JW; Jang MK; Ryu SH; Park NH; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):319-24. PubMed ID: 15195897
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.
Kang HJ; Lee JM; Yoon JH; Yoo J; Kim JH; Park J
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330156. PubMed ID: 37991335
[No Abstract] [Full Text] [Related]
12. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
[TBL] [Abstract][Full Text] [Related]
14. Comparison of imaging characteristics between hepatic benign regenerative nodules and hepatocellular carcinomas associated with Budd-Chiari syndrome by contrast enhanced ultrasound.
Zhang R; Qin S; Zhou Y; Song Y; Sun L
Eur J Radiol; 2012 Nov; 81(11):2984-9. PubMed ID: 22341409
[TBL] [Abstract][Full Text] [Related]
15. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
16. Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.
Kim DH; Choi SH; Kim SY; Kim MJ; Lee SS; Byun JH
Radiology; 2019 Jun; 291(3):651-657. PubMed ID: 30990381
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis.
Ayuso C; Forner A; Darnell A; Rimola J; García-Criado Á; Bianchi L; Vilana R; Oliveira R; Llarch N; Bruix J
Liver Int; 2019 Jul; 39(7):1281-1291. PubMed ID: 31077539
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.
Huang P; Wu F; Hou K; Zhou C; Xiao Y; Wang C; Miao G; Yang C; Zeng M
Eur Radiol; 2024 Apr; 34(4):2271-2282. PubMed ID: 37792079
[TBL] [Abstract][Full Text] [Related]
19. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
